Stock Plans (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Jul. 31, 2023 |
Sep. 30, 2022 |
Aug. 31, 2022 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Aug. 31, 2015 |
Feb. 28, 2014 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
| Common stock outstanding | 93,000 | 46,000 | ||||||
| Weighted-average fair value of options and awards granted | $ 17.66 | $ 19.00 | ||||||
| Total unrecognized compensation expense related to non-vested stock option | $ 0 | |||||||
| Plan 2015 [Member] | ||||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
| Number of shares agreed to issue | 125,000 | 30 | ||||||
| Shares available for grant | 3,750 | |||||||
| Common stock outstanding | 93,059 | 30 | ||||||
| Purchase common stock | 45,000 | 6,250 | ||||||
| Purchase price, per value | $ 26.20 | $ 30.40 | ||||||
| Number of common stock vested | 5,691 | 22,500 | ||||||
| Non-cash stock compensation | $ 48,000 | $ 235,000 | ||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Details
|